i
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil
-
Apr 2013
Source: Emerg Infect Dis. 19(4):589-597.
[PDF-713.91 KB]
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization Program. To assess the vaccine's effectiveness for preventing pneumonia, we analyzed rates of hospitalization among children 2-24 months of age who had pneumonia from all causes from January 2005 through August 2011. We used data from the National Hospitalization Information System to conduct an interrupted time-series analysis for 5 cities in Brazil that had good data quality and high PCV10 vaccination coverage. Of the 197,975 hospitalizations analyzed, 30% were for pneumonia. Significant declines in hospitalizations for pneumonia were noted in Belo Horizonte (28.7%), Curitiba (23.3%), and Recife (27.4%) but not in São Paulo and Porto Alegre. However, in the latter 2 cities, vaccination coverage was less than that in the former 3. Overall, 1 year after introduction of PCV10, hospitalizations of children for pneumonia were reduced.
-
Subject:
-
Source:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
gif 
jpeg 
pdf 
txt
txt 
gif 
jpeg 
gif 
jpeg 
gif 
jpeg 
gif 
jpeg
More +
Email
CDC-INFO
